NCT00948662View on ClinicalTrials.gov

Study Evaluating The Safety And Tolerability Of Administration Of Single Oral Doses Of SAM-760 To Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Healthy
Interventions
DRUG

SAM-760

SAM-760 capsule, 0.25, 0.75, 2.25, 5, 10, 15, 20, 25, 35 and 45mg, single dose, 1 day

DRUG

Placebo of SAM-760

SAM-760 matching placebo capsule, single dose, 1 day,

DRUG

ketoconazole

Ketoconazole oral tablets, 200 mg bid, 14 days

Trial Locations (1)

92502

Pfizer Investigational Site, Rueil-Malmaison

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00948662 - Study Evaluating The Safety And Tolerability Of Administration Of Single Oral Doses Of SAM-760 To Healthy Subjects | Biotech Hunter | Biotech Hunter